BioSpace News Archive

Policy

Palliare Announces EU CE Mark Approval Under New Medical Devices Regulation

Palliare, a leading developer of advanced insufflation technologies, has received EU CE Mark certification under the new EU Medical Devices Regulation for its EVA15 insufflator and smoke evacuation system.

July 28, 2023
·
3 min read
Policy

Curium Receives Marketing Authorization in the EU for PYLCLARI™, an Innovative 18F-PSMA PET Tracer Indicated in Adults With Prostate Cancer

Curium announced that the European Commission has granted marketing authorization for PYLCLARI™ indicated for the detection of prostate-specific membrane antigen positive lesions with positron emission tomography in adults with prostate cancer.

July 28, 2023
·
2 min read
Business

Stevanato Group Reports Second Quarter 2023 Financial Results

Stevanato Group S.p.A. today announced its financial results for the second quarter of 2023.

July 28, 2023
·
18 min read
Business

Augmedix to Announce Second Quarter 2023 Financial Results and Host Investor Conference Call on August 7, 2023

Augmedix today announced it will report financial results for the second quarter ended June 30, 2023, on Monday, August 7, 2023, after the market closes.

July 28, 2023
·
1 min read
Revive Therapeutics Announces Filing of Patent for Bucillamine in the Treatment of Exposure to Chemical Warfare Agents

Revive Therapeutics Ltd. today announced that it has filed a provisional patent application titled “Compositions, methods and uses of Bucillamine in the treatment of a victim exposed to a chemical warfare agent.”

July 28, 2023
·
4 min read
Business

Press release: Online availability of Sanofi’s half-year financial report for 2023

Sanofi announces that its half-year financial report for the period ending June 30, 2023 is now available and has been filed with the French market regulator Autorité des marchés financiers and submitted to the U.S. Securities and Exchange Commission under form 6-K.

July 28, 2023
·
1 min read
Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites

Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites.

July 28, 2023
·
3 min read
First Patient Dosed in Chemotherapy-Free Triple Combination Phase II Trial Targeting Soft Tissue Sarcoma

Immutep Limited today announces the first patient has been enrolled and safely dosed in EFTISARC-NEO, the Phase II investigator-initiated trial of eftilagimod alpha (efti).

July 28, 2023
·
4 min read
Genetown

Merus Announces Two Clinical Abstracts on Zenocutuzumab (Zeno) in NRG1-fusion (NRG1+) non-small cell lung cancer (NSCLC) and Pancreatic Cancer (PDAC) Selected for Presentation at the ESMO Congress 2023

Merus N.V. today announced two abstracts were selected for presentation at the European Society for Medical Oncology Congress (ESMO) 2023.

July 28, 2023
·
5 min read
Business

IO Biotech Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial at University of California Davis Comprehensive Cancer Center

IO Biotech announced today that the University of California Davis Comprehensive Cancer Center has dosed the first patient in its investigator-initiated trial which aims to evaluate IO102-IO103, the company’s investigational immune-modulating cancer vaccine.

July 28, 2023
·
4 min read